oncology 2022 | Melbourne | Australia | Allied Conferences | Meetings

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Innovative Surgical Techniques and Breakthroughs in Surgery

- oncology 2022

About

We want to thank everyone who contributed to making Cancer Summit 2019 a big success, including our incredible keynote speakers, conference attendees, instructors, groups, media partners, exhibitors, and visitors.

Young, smart academics, corporate representatives, and talented student groups from over 18 countries all attended the conference, which was a major factor in its success.

At the symposium, several presentations on contemporary retro-viral research were featured.

The 16th International Conference on Cancer and Cancer Therapy was co-hosted by Allied Academies on November 21–22, 2019, in London, United Kingdom, with the topic "Amalgam of Innovations in Cancer Treatment. "The Editorial Board. This event was a success thanks to the generous and active responses of top academic scientists, doctors, researchers, students, and leaders in the disciplines of cancer and cancer therapy.

The 17th International Conference on Cancer and Cancer Therapy was conducted in virtual mode on November 12, 2021, with the theme "Emerging and Innovative Approaches on Cancer and Cancer Therapy." The Editorial Board This event was successful because top academic researchers, medical professionals, research scholars, students, and experts in the disciplines of cancer and cancer therapy responded generously and energetically.

The 18th International Conference on Cancer and Cancer Therapy was conducted by Allied Academies in Austria on June 13–14, 2022, with the theme "Advanced creative research on Cancer and Cancer Therapy." This event was successful thanks to the Board of Editors' leading academic scientists, doctors, research scholars, students, and leaders in the disciplines of cancer and cancer therapy.

We owe gratitude to various attendees who contributed their expertise, leadership in business, and other noteworthy qualities to the conference by generating lively discussion forums.

We appreciate the organizing committee members' kind contributions, support, and help in making Cancer and Cancer Therapy 2021 a success.

Allied Academies is pleased to announce the "17th International Conference on Cancer and Cancer Therapy," which will be held on August 1 to 2, in Melbourne, Australia This follows the enormous success of Cancer Summit 2019 & 2021.

Please visit for more information.: Cancer 2022

UPDATE FOR August 1-2, 2022! Cancer 2022 will be held in Melbourne, Australia

Cancer Summit 2023 is excited to announce our 20th International Conference on Cancer and Cancer Therapy, which will be held on December 07-09, 2023 in Madrid, Spain. With a strong emphasis on the critical evolution of discoveries and innovations in cancer science research.

This year's theme is "Innovative ideas in oncology"

The Cancer Summit 2023 will bring together renowned scholars from cancer and cancer therapy societies to present and explore the potential of cancer and cancer therapy medicine.

This meeting includes many engaging sessions designed specifically for highly acclaimed educational activity, and it is widely regarded as one of the most important gatherings on the subject.

The goal of the Cancer Summit 2023 is to highlight recent advances and improvements in cancer research and development. Abstracts must contain the author's research data (s).

Presentations will be chosen based on the consistency, style, and other characteristics of their content, which will cover a wide range of cancer sciences as well as relevant policies.

The inclusion of an engaging keynote speaker, lectures, and oral and poster presentation sessions bolstered the conference.

Each presenter will have 30-40 minutes to present his or her research findings, which will be followed by an engaging discussion moderated by leading experts.

The mission of the committee is to foster a supportive, welcoming network environment among participants, making it easy to communicate with other colleges/attendees, exchange ideas, and lay the groundwork for future vision and growth. Come and socialize, interact, network, and collaborate with us at Cancer Summit 2022.

We are delighted to welcome you to this meeting!

Regards

Organizing Committee

Cancer 2022

Welcome Message

We warmly welcome and invite all delegates, speakers, exhibitors, sponsors, and other participants from around the world to attend “International Conference on Oncology”, which is slated on August 01-02, 2022 in Melbourne, Australia.

The theme of the conference is” Peculiar Innovations and Advancement in Clinical Oncology”. The Clinical Oncology conferences 2023 has been carefully curated to meet the outstanding standards of our attendees and thus provides an excellent platform for interactive congregations of knowledge and wisdom about path-breaking research on Clinical Oncology and Pharmacology around the world.

Clinical Oncology Conferences 2023 speakers and attendees come from Various universities, clinics, private and government-sponsored laboratories, and industries around the world. The conference will feature numerous keynote addresses, scientific presentations, and poster exhibitions, highlighting the areas of Clinical oncology, pharmacology, cancer Systems biology, Cancer Pharmacology, and cancer treatment.

We aim to encourage the progress of efforts to explain the untapped medicine behind the mystery of oncology applications, their mechanisms, fabrication, integration of cancer therapy, and management, including an active conversation of novel drugs about recent advances in the field of pharmacology.

We have organized scientific sessions around relevant and cutting-edge topics and engaging workshops and a range of networking sessions to foster dialogue. We would like to take this opportunity to encourage your presence and participation in this unique summit to take advantage of the most recent scientific discoveries and milestones in the fields of Clinical Oncology and Pharmacology.

We believe that the more you participate, the more you will get out of the conference. We invite you to actively participate by taking the opportunity to connect with leading internationally renowned oncologists at Clinical Oncology Conferences 2023. The conference also provides attendees with opportunities to build and renew friendships, network, and collaborate on future ventures and research projects.

We are confident that you will have the opportunity to improve your oncology knowledge and experience and have a great time in London.

We look forward to seeing you in the dazzling city of Melbourne, Australia

Regards,
Organizing Committee
Clinical Oncology 2023

Scientific Sessions/Tracks

Submit your abstracts online Cancer Summit Abstract Submission

E-mail: [email protected]

Following the peer review process, you will be notified by e-mail of the acceptance or rejection of your abstract submission within 2-3 business days.

Conference Benefits:

Eminent Keynote talk,
The Networking panel discussion,
Business-to-business meeting,
Team building with the new contacts,
Get to know your academic idols.
Participate in high-level debates to improve your ideas.
Increasing the value of your CV.
To broaden your horizons and discover solutions to problems.
To share your thoughts and work with other

Cancer and Cancer Therapy:

Submit your abstracts on…

·Cancer Science

·Chemotherapy

·Cancer Genetics & Genomics

·Cancer Immunology

·Cancer Nanotechnology

·Cancer Detection and Techniques

·Cancer Prognosis and Epidemiology

·Cancer Pathophysiology

·Breast Cancer

·Paediatric Cancer

·Gynaecologic and Prostate Cancer

·Oral and Oropharyngeal Cancer

·Blood Cancer

·Role of AI in Cancer

·Palliative Care in Cancer

·Cancer in the gastrointestinal tract

·Types and stages of Cancer.

Session 01 on Cancer Science:

Cancer science focuses on the biological mechanisms behind cancer and the development of new strategies for its diagnosis, treatment, and prevention. Cancer is a complex and multifaceted disease, and cancer science encompasses a wide range of disciplines, including genetics, cell biology, immunology, and clinical research.

Current research in cancer science:

One of the most promising areas of research is immunotherapy, which aims to harness the power of the immune system to fight cancer. This approach has shown remarkable success in treating certain types of cancer, including melanoma and lung cancer, and researchers are working on expanding its applications to other types of cancer.

Cancer science is a rapidly evolving field with many exciting developments and breakthroughs on the horizon. Researchers are working tirelessly to improve our understanding of cancer and develop new strategies for preventing, diagnosing, and treating this devastating disease.

Sub tracks:

Tumour microenvironment and its role in cancer progression

The relationship between cancer and chronic inflammation

Cancer health services and outcomes research.

The Role of the extracellular matrix in cancer cell migration and Invasion

The impact of circadian rhythm disruption on cancer development and progression

Session 02 on Chemotherapy:

Chemotherapy is a type of cancer treatment that uses drugs to kill cancer cells. These drugs are often administered intravenously, but can also be given orally or topically. Chemotherapy drugs work by targeting rapidly dividing cells, which includes cancer cells, but can also affect healthy cells in the body.

There are many different chemotherapy drugs, and they are often used in combination with other treatments such as surgery and radiation therapy. The specific chemotherapy drugs used and the treatment regimen will depend on the type of cancer being treated, the stage of the cancer, and other factors.

While chemotherapy can be very effective in killing cancer cells, it can also have side effects because it can also affect normal, healthy cells in the body. Some common side effects of chemotherapy include nausea, vomiting, hair loss, fatigue, and increased risk of infection. However, advances in chemotherapy drug development and supportive care measures have improved the management of these side effects.

Sub tracks:

Combination chemotherapy and dose optimization

Chemo brain

Hyperthermic intraperitoneal chemotherapy (HIPEC)

Metronomic chemotherapy

Chemotherapy-induced peripheral neuropathy (CIPN)

Session 03 on Cancer Genetics and Genomics:

Cancer genetics and genomics is a field of study that focuses on understanding the genetic and genomic changes that occur in cancer cells. These changes can lead to the development and progression of cancer, and studying them can provide insights into how cancer develops, how it can be diagnosed, and how it can be treated.

Researchers in cancer genetics and genomics study various aspects of cancer genetics, including mutations in genes that can lead to cancer development, the interaction between genes and environmental factors, and the identification of new targets for cancer therapies.

One important area of cancer genetics and genomics is the study of cancer predisposition genes. These are genes that, when mutated, increase an individual's risk of developing certain types of cancer. By identifying individuals who carry mutations in these genes, doctors can develop screening and prevention strategies to help detect and prevent cancer at an early stage.

Another important area of research in cancer genetics and genomics is the use of genomic sequencing to identify the specific genetic mutations that are driving a patient's cancer. This information can help doctors select the most effective treatments and develop personalized treatment plans tailored to each patient’s unique genetic makeup.

Sub tracks:

Genome-wide association studies (GWAS) in cancer

Tumour heterogeneity and clonal evolution

On co-genomics

Cancer stem cells

Non-coding RNAs and cancer

Session 04 on Cancer Immunology:

Cancer Immunology is a branch of medical science that studies the interactions between the immune system and cancer cells. The immune system plays a critical role in detecting and eliminating cancer cells, but cancer cells can evade immune surveillance and grow uncontrollably. Cancer Immunology seeks to understand how the immune system can be activated and harnessed to effectively target and destroy cancer cells.

Research in Cancer Immunology focuses on several areas, including the identification of tumor antigens, the development of cancer vaccines and immunotherapies, and the study of the tumor microenvironment and immune cell infiltrates. Recent advances in Cancer Immunology have led to the development of several FDA-approved immunotherapies, such as immune checkpoint inhibitors and CAR-T cell therapies, that have revolutionized cancer treatment and improved patient outcomes.

Sub tracks:

Cancer vaccines

Immunogenomics

Immune checkpoint inhibitors

Preclinical models

Session 05 on Cancer Nanotechnology:

Cancer nanotechnology is a rapidly evolving field that aims to develop novel nanoscale materials and devices for the diagnosis, imaging, and treatment of cancer. Nanotechnology is the manipulation of materials and devices at the nanoscale level, which is approximately 1 to 100 nanometers in size. This small size allows nanoparticles and nanodevices to interact with biological systems in unique ways, including improved cellular uptake, increased blood circulation time, and enhanced targeting of cancer cells.

In cancer nanotechnology, nanoparticles can be designed to selectively target cancer cells, deliver drugs directly to the tumor site, and enhance the efficacy of chemotherapy and radiation therapy. Nanoparticles can also be used for imaging and diagnosis, allowing for earlier detection and more accurate characterization of tumors.

Recent research in cancer nanotechnology has focused on developing multifunctional nanoparticles that can perform multiple tasks simultaneously, such as targeting, imaging, and drug delivery. Additionally, researchers are exploring the use of nanoscale devices and systems for cancer therapy, including nanorobots that can selectively destroy cancer cells and nanoscale sensors that can detect and monitor cancer in real time.

Sub tracks:

platforms for early cancer Nanoparticle-based hyperthermia

Nanoparticle-based photodynamic therapy

Tumor-associated antigen (TAA) nanoparticles.

Nanoengineered detection

Session 06 on Cancer detection and techniques:

Cancer detection refers to the process of identifying the presence of cancer cells or tumors in the body through various diagnostic techniques. The goal of cancer detection is to identify cancer at an early stage when treatment is more effective and the chances of a cure are higher.

Sub tracks:

Endoscopy

Bioluminescence imaging

Biopsy techniques

Mass spectrometry

Point-of-care testing

Session 07 on Cancer Prognosis and Epidemiology:

Cancer prognosis and epidemiology are two important areas of cancer research that are concerned with predicting the outcome of cancer and understanding the distribution and determinants of cancer in populations.

Cancer prognosis refers to the process of predicting the likely course and outcome of particular cancer, based on various factors such as the type and stage of cancer, the patient's age and overall health, and the response to treatment. Prognosis is an important consideration in cancer treatment, as it can help guide treatment decisions and inform patients and their families about the expected outcomes.

Cancer epidemiology, on the other hand, is the study of the distribution and determinants of cancer in populations, including factors such as environmental exposures, lifestyle choices, genetic predisposition, and socio-economic factors. Epidemiology is used to identify risk factors for cancer and to guide public health interventions aimed at reducing the incidence and mortality of cancer.

Both cancer prognosis and epidemiology are important areas of cancer research that are essential for understanding the causes and outcomes of cancer, as well as for developing new strategies for cancer prevention, detection, and treatment.

Sub tracks:

Prognostic biomarkers

Tumour staging and grading

Metabolomics

Digital pathology

Psychosocial Factors on Prognosis and Epidemiology

Session 08 on Cancer Pathophysiology:

Cancer pathophysiology is the study of the underlying physiological changes and processes that occur in cancer cells and how they contribute to the development, progression, and spread of cancer. It involves understanding the mechanisms by which normal cells become transformed into cancer cells, and how cancer cells acquire the ability to evade the immune system, invade surrounding tissues, and metastasize to distant organs.

Cancer pathophysiology also encompasses the study of the tumor microenvironment, including the interactions between cancer cells and their surrounding stromal cells, extracellular matrix, and blood vessels. It involves investigating the molecular pathways that are dysregulated in cancer cells, including mutations in oncogenes and tumor suppressor genes, alterations in DNA repair mechanisms, and aberrant signaling pathways.

The goal of cancer pathophysiology research is to deepen our understanding of the biological mechanisms that drive cancer development and progression, with the ultimate aim of identifying new targets for cancer treatment and developing more effective therapies.

Sub tracks:

Signaling Pathways

Oncogenes and Tumour Suppressor Genes

Angiogenesis

Cell Cycle Regulation

Tumour Heterogeneity

Session 09 on Breast Cancer:

Breast cancer is a type of cancer that starts in the cells of the breast. It occurs when abnormal cells in the breast grow and divide uncontrollably, forming a lump or mass. Breast cancer can develop in both men and women, but it is more common in women.

There are several types of breast cancer, but the most common type is invasive ductal carcinoma, which starts in the milk ducts and spreads to other parts of the breast. Other less common types include invasive lobular carcinoma, inflammatory breast cancer, and Paget's disease of the nipple.

Breast cancer can cause a variety of symptoms, including a lump or thickening in the breast, changes in the shape or size of the breast, nipple discharge, and skin changes around the breast or nipple. However, many people with breast cancer have no symptoms at all.

Early detection is important for the successful treatment of breast cancer. Women are advised to perform breast self-exams regularly and to have regular mammograms, particularly as they get older or if they

Sub tracks:

Triple-negative breast cancer

Mammography

HER2-positive breast cancer

Male breast cancer

Metastatic Breast cancer

Session 10 on Paediatric Cancer:

Pediatric cancer refers to cancer that develops in children and young adults. It is a relatively rare disease, with about 15,000 new cases diagnosed in the United States each year. The most common types of pediatric cancer include leukemia, brain tumors, and lymphoma, but there are many other types that can occur.

Pediatric cancer is different from adult cancer in several ways. Children's bodies are still developing, so their cells may respond differently to cancer treatments than adult cells. Additionally, children may experience different side effects from cancer treatments, and they may require specialized care to manage these side effects.

The causes of pediatric cancer are not fully understood, but researchers believe that genetic and environmental factors may play a role. Some genetic conditions, such as Down syndrome and Li-Fraumeni syndrome, are associated with an increased risk of pediatric cancer.

Treatment for pediatric cancer typically involves a combination of surgery, chemotherapy, and radiation therapy, depending on the type and stage of cancer. Because children's bodies are still growing and developing, doctors often take a more conservative approach to treatment than they would with adult patients, in order to minimize long-term side effects.

Survival rates for pediatric cancer have improved significantly in recent years, thanks to advances in cancer treatment and supportive care. However, many children and their families still face significant challenges during and after treatment, including long-term side effects, emotional and social impacts, and financial burdens. Ongoing research is focused on developing new and more effective treatments for pediatric cancer, as well as improving supportive care for patients and families.

Sub tracks:

Wilms tumor

Neuroblastoma

Retinoblastoma

Osteosarcoma

Medulloblastoma

Session 11 on Gynaecologic and Prostate Cancer:

Gynaecologic cancer refers to cancers that develop in a woman's reproductive system, including the cervix, ovaries, uterus, fallopian tubes, and vagina. These types of cancer can affect women of all ages and can have a significant impact on a woman's physical and emotional health.

Some common symptoms of gynecologic cancer include abnormal vaginal bleeding, pelvic pain or pressure, vaginal discharge, and changes in bowel or bladder habits. However, many women with gynecologic cancer do not experience any symptoms, which is why regular screenings and check-ups are important for early detection.

Prostate cancer is a type of cancer that develops in the prostate gland, which is a part of the male reproductive system. Prostate cancer is one of the most common types of cancer in men, and it can develop slowly or quickly depending on the individual case. Symptoms of prostate cancer can include difficulty urinating, decreased urine flow, blood in the urine or semen, and erectile dysfunction.

Treatment options for gynecologic and prostate cancer depend on the type and stage of cancer, as well as the patient's overall health and other individual factors. Treatment options may include surgery, radiotherapy, chemotherapy, hormone therapy, or targeted therapy. It is important for patients to work closely with their healthcare team to determine the best treatment plan for their individual cases.

Sub tracks:

Gestational trophoblastic disease

Fallopian tube cancer

Ovarian cancer

Prostate cancer diagnosis

Treatment for prostate cancer

Session 12 on Oral and Oropharyngeal Cancer:

Oral and oropharyngeal cancer are types of cancer that affect the mouth and throat. Oral cancer typically affects the lips, tongue, cheeks, and gums, while oropharyngeal cancer affects the middle part of the throat, including the tonsils and base of the tongue.

These types of cancer are often linked to lifestyle factors such as tobacco and alcohol use, as well as exposure to the human papillomavirus (HPV). Symptoms may include persistent mouth or throat pain, difficulty swallowing or speaking, a lump or sore that doesn't heal, or changes in the appearance of the mouth or throat.

Diagnosis typically involves a physical exam, biopsy, and imaging tests such as CT or MRI scans. Treatment options may include surgery, radiotherapy, chemotherapy, or a combination of these approaches, depending on the stage and location of cancer.

Early detection is important for the successful treatment of oral and oropharyngeal cancer, and regular dental check-ups and screenings can help identify potential problems. Reducing or eliminating tobacco and alcohol use and practicing safe sex to reduce the risk of HPV infection can also help lower the risk of developing these types of cancer.

Sub tracks:

Minor salivary gland carcinomas.

Verrucous carcinoma

Symptoms of Oral Cancer

Treatment for Oral Cancer

Tonsils Cancer

Session 13 on Blood Cancer:

Blood cancer, also known as hematologic cancer, is a type of cancer that affects the blood, bone marrow, and lymphatic system. Bone marrow is a soft, spongy tissue found inside the bones, where blood cells are produced. In blood cancer, there is an abnormal growth of blood cells or when the blood cells do not function normally, which can affect the bone marrow.

Leukaemia is a type of blood cancer that affects white blood cells. It occurs when the bone marrow produces too many abnormal white blood cells, which can prevent the production of healthy red blood cells and platelets. The abnormal white blood cells also do not function properly and can accumulate in various organs, causing damage.

Lymphoma is a type of blood cancer that affects the lymphatic system, which is a network of vessels and organs that help to fight infections. It occurs when abnormal lymphocytes, a type of white blood cell, grow out of control and form tumors in the lymph nodes or other parts of the body. The tumors can affect the bone marrow and interfere with the production of blood cells.

Myeloma is a type of blood cancer that affects the plasma cells, which are a type of white blood cell that produces antibodies. It occurs when abnormal plasma cells accumulate in the bone marrow and form tumors, which can cause bone pain and fractures.

Bone marrow plays a critical role in the development of healthy blood cells. In blood cancer, the abnormal growth of blood cells can interfere with the production of normal blood cells, which can lead to a range of symptoms and complications. Treatment options for blood cancer may include chemotherapy, radiotherapy, targeted therapy, or stem cell transplantation, which aims to destroy the abnormal blood cells and restore the normal functioning of the bone marrow.

Sub tracks:

Chronic Lymphocytic Leukaemia (CLL)

Myelodysplastic Syndrome (MDS)

Myeloproliferative Neoplasms (MPN)

Hodgkin's and Non-Hodgkin’s Lymphoma

Session 14 on Role of AI in Cancer:

The role of AI in cancer is becoming increasingly important as technology advances. AI has the potential to revolutionize cancer detection, diagnosis, treatment, and monitoring, improving patient outcomes and saving lives. Here are a few ways in which AI is being used in cancer:

Early detection: AI can analyze large amounts of data from medical images, such as mammograms or CT scans, to identify abnormalities that might indicate cancer. This can lead to earlier detection and treatment when cancer is more easily treatable.

Diagnosis: AI can assist pathologists and radiologists in diagnosing cancer by analyzing tissue samples and medical images, providing more accurate and efficient diagnoses.

Treatment planning: AI can help oncologists develop personalized treatment plans for cancer patients, based on the patient's genetic makeup and medical history, as well as data from previous cases.

Monitoring treatment: AI can analyze patient data, such as lab results and medical images, to monitor the effectiveness of cancer treatments and make adjustments as needed.

Drug discovery: AI can help identify new cancer treatments by analyzing large amounts of data from drug trials, scientific publications, and genetic data.

Sub tracks:

Radiomics and radio genomics

Robotic Oncology

Predictive modeling

Natural language processing

Image-guided surgery

Session 15 on Palliative Care in Cancer:

Palliative care is a specialized approach to caring for individuals with serious illnesses, including cancer, with the goal of improving their quality of life. Palliative care is provided by a team of healthcare professionals, including doctors, nurses, social workers, and chaplains, who work together to address the physical, emotional, and spiritual needs of the patient and their family.

In cancer care, palliative care is often provided alongside curative treatment, with the aim of managing symptoms and improving quality of life throughout the treatment process. Palliative care can include pain management, symptom control, emotional and spiritual support, and assistance with end-of-life planning.

Palliative care can also be provided to patients who have advanced or terminal cancer, with the goal of ensuring that they are as comfortable and supported as possible during their final months of life. This may include pain management, symptom control, and counseling for the patient and their family.

Sub tracks:

Pain Management Techniques in palliative care for cancer patients

Ethical Considerations in palliative care for cancer patients

Spiritual care and psychological support in palliative care for cancer patients

Advance care planning and end-of-life decision-making in cancer patients

Lifestyle and Nutrition in Cancer Care

Session 16 on Radiation Oncology:

Radiation Oncology is a branch of medicine that deals with the use of high-energy radiation to treat cancer. It involves the use of ionizing radiation, such as X-rays and gamma rays, to kill cancer cells or prevent them from growing and dividing.

The radiation used in radiation oncology is delivered by a machine called a linear accelerator, or linac, which generates high-energy X-rays or electrons. The radiation can also be delivered using radioactive implants, such as brachytherapy, or through a radioactive source that is placed on or near the tumor site.

Radiation Oncology is used to treat a variety of cancers, including breast cancer, lung cancer, prostate cancer, and brain tumors. It can also be used in combination with other cancer treatments, such as chemotherapy and surgery, to provide a more comprehensive approach to cancer care.

During Radiation Oncology treatment, the radiation is carefully targeted to the cancerous cells in order to minimize damage to healthy cells and tissues. The treatment is typically administered over a period of several weeks, with patients receiving small doses of radiation each day.

Side effects of Radiation Oncology can include fatigue, skin irritation, and nausea, among others. However, these side effects are usually temporary and can be managed with medication or other supportive therapies.

Sub tracks:

Radiotherapy Techniques

Radiosensitizers

Brachytherapy

Radio biomarkers

Radioprotection

Session 17 on Surgical Oncology:

Surgical oncology is a specialized field of medicine that focuses on the surgical management of cancer. Surgeons who specialize in this field are known as surgical oncologists. They work closely with other members of a cancer treatment team, such as medical oncologists, radiation oncologists, and pathologists, to provide comprehensive care for cancer patients.

Surgical oncologists perform various types of cancer surgeries, such as biopsies, tumor removals, lymph node dissections, and reconstructive surgeries. They use various techniques to minimize the impact of surgery on a patient's quality of life, such as minimally invasive surgery, which uses small incisions and advanced technology to remove cancerous tissue with less damage to healthy tissue.

Surgical oncologists also play an important role in the diagnosis and staging of cancer, as they often perform biopsies and other diagnostic procedures to determine the extent and characteristics of a patient's cancer. They may also be involved in clinical trials to test new surgical techniques or treatments for cancer.

Surgical oncology is an important component of cancer care, and surgical oncologists play a critical role in the management and treatment of cancer patients.

Sub tracks:

Robotic Surgery

Precision Surgery

Hepatobiliary and Pancreatic Surgery

Sentinel Lymph Node Biopsy

Reconstruction Surgery

Session 18 on Neuro-Oncology:

Neurooncology is a subspecialty of oncology that focuses on the diagnosis and treatment of tumors affecting the brain and nervous system. These tumors can be cancerous (malignant) or non-cancerous (benign) and can occur at any age, although some types are more common in children or adults.

The field of neuro-oncology is interdisciplinary and involves collaboration between neurologists, neurosurgeons, medical oncologists, radiation oncologists, and other specialists to provide comprehensive care for patients with brain and nervous system tumors. Treatment options for neuro-oncology may include surgery, radiotherapy, chemotherapy, targeted therapy, immunotherapy, or a combination of these modalities.

Some common types of brain and nervous system tumors include gliomas, meningiomas, pituitary tumors, acoustic neuromas, and medulloblastomas. Neurooncologists may also treat tumors that have spread from other parts of the body to the brain or spinal cord (metastatic tumors).

Due to the complexity of the nervous system and the potential risks associated with treatment, neurooncology requires specialized training and expertise. Neurooncologists must be skilled in the diagnosis and management of brain and nervous system tumors, as well as in the management of neurological complications that may arise during treatment.

Sub tracks:

Neuroimaging

Paediatric Neuro-Oncology

Neuro-Oncology Nursing

Stereotactic Radiosurgery

Session 19 on Dermatologic Cancer:

Dermatologic cancer, also known as skin cancer, is a type of cancer that affects the skin. It is one of the most common types of cancer, with over a million cases diagnosed each year in the United States alone.

There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma. Basal cell carcinoma and squamous cell carcinoma are the most common types and are typically caused by exposure to ultraviolet (UV) radiation from the sun or tanning beds. Melanoma is a less common but more dangerous type of skin cancer that can spread to other parts of the body if not detected and treated early.

The diagnosis of dermatologic cancer typically involves a skin biopsy, where a sample of skin tissue is taken and examined under a microscope for signs of cancer. Treatment for dermatologic cancer varies depending on the type, stage, and location of cancer, but may include surgery, radiotherapy, chemotherapy, and immunotherapy.

Prevention of skin cancer involves protecting the skin from exposure to UV radiation by wearing protective clothing, using sunscreen with a high SPF, and avoiding tanning beds. Early detection and treatment are also important for improving outcomes for patients with skin cancer.

Sub tracks:

Photodynamic Therapy

Merkel Cell Carcinoma

Skin Cancer Prevention

Dermato-oncology Nursing

Cutaneous Lymphoma

Session 20 on Cancer in the gastrointestinal tract:

Cancer in the gastrointestinal tract refers to cancers that occur in the digestive system, which includes the esophagus, stomach, small intestine, colon, rectum, anus, liver, pancreas, and gallbladder. These cancers may develop from the cells that line the digestive system or from the glands or tissues within the digestive system.

Symptoms of gastrointestinal tract cancer may include abdominal pain, changes in bowel habits, nausea and vomiting, unexplained weight loss, and blood in the stool. Diagnosis typically involves imaging tests, such as CT scans and MRIs, as well as endoscopic procedures, such as colonoscopy or upper endoscopy, which allow doctors to visualize the inside of the digestive system and take tissue samples for biopsy.

Treatment for gastrointestinal tract cancer depends on the type and stage of cancer, as well as the location and extent of the tumor. Treatment options may include surgery, chemotherapy , radiotherapy, targeted therapy, and immunotherapy. In some cases, a combination of treatments may be used.

Gastrointestinal tract cancer can be a serious and life-threatening condition, but early detection and prompt treatment can improve outcomes. Regular screening for certain types of gastrointestinal tract cancers, such as colon cancer, is recommended for individuals at increased risk.

Sub tracks:

Gut Microbiota Implications in Cancer

Liver cancer

Neuroendocrine tumors

Gastrointestinal stromal tumors

Anal cancer

Session 21 on Types and stages of Cancer:

Cancer is a complex and varied disease that can affect different parts of the body in different ways. To help diagnose and treat cancer, doctors use a system of classification based on two main factors: the type of cancer and the stage of the cancer.

Types of cancer refer to the specific part of the body where cancer first develops and the type of cells that make up cancer. There are many different types of cancer, including breast cancer, lung cancer, prostate cancer, colon cancer, skin cancer, and many others.

Stages of cancer refer to how far cancer has progressed and how much it has spread from its original location. There are several different staging systems used for different types of cancer, but they generally follow a similar format. The stages are typically numbered from 0 to IV, with higher numbers indicating more advanced disease. The stages are determined based on factors such as the size of the tumor, whether it has spread to nearby lymph nodes, and whether it has spread to other parts of the body.

Understanding the type and stage of cancer is crucial in determining the most appropriate treatment options and predicting the outcome of the disease. It is important to work closely with a healthcare team to develop a personalized treatment plan based on individual factors such as age, overall health, and the characteristics of cancer itself.

Sub tracks:

Lung and Thyroid Cancer

Molecular classification of cancer

Metastasis

Causes and prevention of cancer

Warning signs of cancer

Market Analysis

CANCER AND CANCER TREATMENT MARKET ANALYSIS

The "Global Market for Cancer and Cancer Therapy" 2023-2031 The research report offers both qualitative and quantitative insights into the major forces, limitations, opportunities, and challenges impacting the expansion of the global market. The research provides detailed statistical market data on the top competitors, along with earnings forecasts. The Cancer Gene Therapy Market Report examines future growth factors as well as the present state of market share, and penetration of various types, technologies, applications, and regions through 2031.

The Cancer Therapeutics market has witnessed growth from USD million to USD million from 2017 to 2022. With the CAGR, this market is estimated to reach USD million in 2029. More than 45% of the Prostate Cancer Industry revenues are expected to come from the North American market in 2023. The Market share of prostate cancer in Europe is projected to increase to 32% by 2033. The Market share for prostate cancer in Asia Pacific is forecast to reach 26% by 2033.

Chemotherapy, hormonal treatment, targeted or biological therapy, and other approaches can all be used to treat this condition. The FDA is approving further new trials for treatments and medications that will be put on the market soon. According to a new study by Moon Hyung Choi and colleagues, pre-biopsy MRIs can successfully stop needless biopsies in persons with PSA levels above 20 ng/ml.

Global cancer diagnostics market: The global cancer diagnostics market was valued at USD 168.6 billion in 2020 and is expected to grow at a CAGR of 7.6% from 2021 to 2028, according to Grand View Research. Factors driving the growth of the cancer diagnostics market include the increasing demand for non-invasive and accurate diagnostic tools, rising awareness and screening programs, and growing research and development activities.

Global cancer treatment market: The global cancer treatment market is expected to grow significantly in the coming years, driven by the increasing demand for targeted therapies, immunotherapies, and personalized medicine. According to a report by Zion Market Research, the global cancer immunotherapy market was valued at USD 73.5 billion in 2020 and is expected to grow at a CAGR of 11.8% from 2021 to 2028.

Major players in the global cancer market: Some of the major players in the global cancer market include Roche Holdings AG, Pfizer Inc., Novartis International AG, Johnson & Johnson, Bristol-Myers Squibb Company, AstraZeneca PLC, and Merck & Co. Inc.

Regional analysis: North America is currently the largest market for cancer treatment, accounting for a significant share of the global market. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period, driven by factors such as increasing cancer incidence, rising healthcare expenditure, and growing adoption of advanced therapies.

Challenges: The high cost of cancer treatment and the lack of access to healthcare facilities in low-income countries are some of the major challenges faced by the cancer market. Efforts to improve access to cancer care, as well as the development of innovative and cost-effective therapies, are critical for addressing these challenges and improving cancer outcomes worldwide.

Overall, the global market for cancer and cancer treatment is expected to continue growing in the coming years, driven by technological advancements and increasing demand for effective and personalized therapies. However, addressing challenges such as cost and access to care will be critical for ensuring that these advancements benefit patients worldwide.

Predicted Cancer Incidence and Mortality in 2023:

Due to the time needed for data collection, compilation, quality control, and dissemination, the most recent year for which incidence and mortality statistics are available is behind the present year by 2-4 years. Therefore, we anticipate the number of new cancer cases and deaths in the United States in 2023 to calculate the current cancer burden using two-step statistical modeling.

Applying the data-driven join point method to cancer fatalities recorded from 2006 through 2020 at the state and national levels as reported by the NCHS, the estimation of the number of cancer deaths anticipated to occur in 2023 was made. The estimated cancer cases for 2023 reported here are based on incidence data that are currently available through 2019 and do not take the COVID-19 pandemic into account. In contrast, the projected cancer deaths for 2023 are based on data that are currently available through 2020 and only take the first year into account. Furthermore, because most cancer registries do not record diagnoses for basal cell and squamous cell skin cancers, estimates for these conditions cannot be made.

Key players:

F. Hoffmann-La Roche Ltd
Novartis AG
Celgene Corp
AstraZeneca Plc
Siemens Healthcare Diagnostics

Treatments:

Cancer treatment options include:
Surgery
Chemotherapy
Radiation therapy
Bone marrow transplant
Immunotherapy
Hormone therapy
Targeted drug therapy
Cryoablation
Radiofrequency ablation
Clinical trials

Treatment Research: (2022-2023)

The international cancer therapeutics market in London is expected to grow at a compound annual growth rate (CAGR) of 7.4% between 2017 and 2022, from $121 billion in 2017. Lung cancer is expected to grow at a compound annual growth rate (CAGR) of 7.6% from $15.7 billion in 2017 to $22.6 billion in 2022. Stomach cancer is expected to increase at a 7.7% CAGR from $8.2 billion in 2017 to $11.9 billion in 2022.

Over 14 million new cases of cancer are expected to be diagnosed this year, making cancer the world's second leading cause of death. With over 8 million deaths, resistant and chronic metastatic disease is the cause of over 90% of deaths in industrial monetary societies. The global burden of cancer is expected to rise to 21.7 million new cases and 13 million cancer deaths by 2030 simply due to population growth and aging.

More than 1. 8 million cancer cases are expected to be reported in 2021. This prediction excludes carcinoma in situ (non-invasive cancer) of any location other than the urinary bladder, as well as Basal cell and squamous cell skin cancer because these types of skin cancers are not required to be mentioned to cancer. According to state sources, new cancer instances are expected in 2021.

Every year, more than 10 million people worldwide are affected by cancer, and this figure is expected to rise by 2.4 percent per year by 2021, reaching 14 million. Cancer is the second leading cause of death in the developed world. The global oncology drug market, valued at $97,401 million, is expanding as people become more aware of life-threatening diseases and rising healthcare costs. Australia is the leading cancer research region in the world. Colorectal cancer is the most dangerous type of cancer. Certain chemicals, including benzene, beryllium, asbestos, vinyl chloride, and arsenic, have been linked to human cancer. Cancer Rem

• American Cancer Society

• American Neoplasm Association

• American Childhood Cancer Organization

• American Faculty of Radiation medical specialty

• American Head and Neck Society

• Association of Cancer Online Resources

• Association of medical specialty welfare work

• Association of European Cancer Leagues

• Association of Cancer Physicians

• Australian carcinoma Trials cluster

• Australian Cervical Cancer Foundation

• Australian Society of Gynaecologic Oncologists

• Avon carcinoma Cruscade

• Bano summary (UICC)

• Barbados Cancer Society

• Bangladesh Cancer Society

• Bladder cancer in North American country

• Cancer specializes in Northern Island

• Children with Cancer United Kingdom of Great Britain and Northern Ireland

• Global carcinoma

• International Society of Oncular medical specialty

• UK medical specialty Nursing Society

• UKCRC Registered CTU Network

• United Kingdom of Cancer Association of Cancer Registries

Why Cancer Summit 2023?

At this event, give presentations, distribute information, network with current and potential scientists, make a splash with new cancer discoveries, and gain name recognition. This conference includes world-renowned speakers, cutting-edge strategies, innovations, and the most recent update

A place where you can express your beliefs while still ensuring their validity.

Socializing and networking with your co-workers and supervisors.

Collaborations, career advancement, and personal engagement all contribute to a bright future.

Getting out of your comfort zone is never easy, particularly when it comes to giving speeches about self-analysis.

Who is to attend?

Cancer Experts, Cancer Specialists, Oncologists, Radiologist, Gynaecologists, Bioinformatics Departments, Biomedical Departments, Professors, and Students, Cancer Research Universities, Haematologists, Cancer Associations and Societies, Public Health Departments, NGO’s, Health Clubs, Manufacturing Medical Devices Companies, Consultants, Specialist Nurses, General Surgeons, Internal Medicine Specialists/Internists, Business Experts in field of Cancer and Medical Devices, Patient Advocates…

Metrics

Allied Group is one of the world’s most remarkable Scientific Conference Organizers who have their individuality on all the spectrums of Science, Technology, and Business. A part of every conference series’ success specifically hangs on to how far it reaches the online community. Having an online audience is critical to make an international gathering a great success; be it research or academic or industrial.

Research personnel, Academicians, Research institutes, Industrialists, and students from the field of Cancer are the key participants who show an intense desire in attending the Cancer& Cancer Therapy conference put forth by Allied Conferences. Conferences based on Cancer & Cancer Therapy studies show a significantly large number of unique visitors and page views which proved to be a thriving success. The following are the readership metrics for the

Allied further extends its frontier by maintaining every conference proceeding on its respective conference web pages and its official social media accounts. Thus, aspiring to have the participation of the international scientific and industrial communities to come and experience the pack of talks, discussions, product exhibitions, and alliances.